Effect of Chronic Pretreatment of Angiotensin-Converting Receptor Blocker on No-Reflow Phenomenon in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
Article first published online: 17 APR 2013
© 2012 Blackwell Publishing Ltd
Volume 31, Issue 3, pages e7–e11, June 2013
How to Cite
Hu, T., Wang, H.-C., Wang, R.-T., Lv, A.-L., Luan, R.-H., Li, C.-X., Cheng, H.-X., Xia, C.-H. and Tao, L. (2013), Effect of Chronic Pretreatment of Angiotensin-Converting Receptor Blocker on No-Reflow Phenomenon in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention. Cardiovascular Therapeutics, 31: e7–e11. doi: 10.1111/j.1755-5922.2012.00314.x
- Issue published online: 17 APR 2013
- Article first published online: 17 APR 2013
- Accepted manuscript online: 10 APR 2012 08:22AM EST
- 2Predictive factors of myocardial reperfusion in patients with anterior wall acute myocardial infarction. Cardiol J 2008;15:57–62., , , .
- 6The diagnosis and treatment of the no-reflow phenomenon in patients with myocardial infarction undergoing percutaneous coronary intervention. Exp Clin Cardiol 2008;13:121–128., , .
- 10Management of ‘no-reflow’ complicating reperfusion therapy. Acute Card Care 2008;10:5–14., .
- 12Large clinical trials of ARB in Japan and its reflection to new guidelines. Nippon Rinsho 2009;67:69–74..
- 14Pharmacological characteristics of ARB and potential strategy to develop novel ARB. Nippon Rinsho 2009;67:812–818..